ICOS and neoplasm: The inducible T cell co-stimulator (ICOS) is a co-stimulator with the ability to induce tumor immunity by stimulating T cells, including cytotoxic T lymphocytes (CTLs) and Th cells, while promoting immune evasion by stimulating Treg cells.